Trabectedin shortage — IT supply status & alternatives

Trabectedin

—

🇦🇺 AUST R 332001

In supply · Australia

Trabectedin/Teva

In supply · 🇦🇺 Australia · short in🇮🇹 IT🇬🇷 GR

In supply in Australia

Reading today’s signals…

🇦🇺 AUAEMPA$809.22details →

✓ Can I substitute?

In supply

no shortage substitution needed

⇄ Best alternative

None listed

refer to prescriber

◷ Expected back

No estimate

No estimate provided

Product attributes reference data we hold

Brand names
Active ingredient (INN)	Trabectedin

Therapeutic category	Auto-created by National Organisation for Medicines — Drug Shortages scraper

Controlled substance	No

Marketing-authorisation holders	Accord Healthcare S.L.U., NATCO PHARMA (CANADA) INC

Registrations on file	3

Patient information leaflet (PIL)	Not on file

Summary of product characteristics (SPC)	Not on file

Trade price 🇦🇺 PBS · July 2026

🇦🇺 AU

● Official price on file

Ex-manufacturer

A$809.22

AEMP

Dispensed (DPMQ)

—

incl. fees

Pack

trabectedin 1 mg injection, 1 vial

Source: PBSEffective July 2026 · AUD

Substitution pathways 🇦🇺 Australia · TGA

—

No substitution instrument in force

Dispense per normal rules, or refer to the prescriber. No active SSSI/S19A instrument detected for this medicine.

Global API supply base 🇺🇸 FDA Drug Master Files · active Type II

6 API manufacturers

Manufacturers with an active Type II Drug Master File — i.e. cleared to supply this active ingredient into the US market. A proxy for how concentrated the global manufacturing base is.

Moderate concentration risk

Shanghai Haoyuan Chemexpress CO LTDPharma Mar SAMsn Laboratories Private LTDApicore LLCBrightgene Bio-Medical Technology CO LTDExtrovis AG

Manufacturing countries: China, Spain, India · Source: FDA List of Drug Master Files

Verified timeline regulator events

🇬🇷 30 June 2026

medium reported

🇮🇹 16 Mar 2026

Shortage resolved

🇮🇹 1 Jan 2026

critical reported

🇮🇹 1 Aug 2025

critical reported

Registration recordmarketing-authorisation holders

Registrations & marketing-authorisation holders3 registrations · 2 MA holders

Product	Strength	Form	Market	MA holder	Status
YONDELIS trabectedin	1 mg	—	🇦🇺 AU	—	Active
Trabectedin Accord	—	—	🌐 EU	Accord Healthcare S.L.U.	Active
Nat-Trabectedin	—	solution	🇨🇦 CA	NATCO PHARMA (CANADA) INC	Active

For health-professional reference only. Mederti aggregates shortage and substitution information from official regulatory sources. It is not clinical advice and data may be incomplete or delayed. Confirm any substitution or supply decision against the primary regulator source, the prescriber, and current clinical references (e.g. AMH) before acting. Terms.